Summary
- Current Price
- As of today, SEEL price is $1.28, with unknown change on
- Current Price All-Time High
- SEEL price is currently at its all-time high
- Market Cap
- SEEL current market cap is $558K, with unknown 1-year change
- PE Ratio
- SEEL current PE ratio is 0.01
- Revenue
- SEEL current annual revenue is $2.20M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for SEEL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Seelos Therapeutics, Inc. |
| Ticker | NASDAQ: SEEL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | seelostherapeutics.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.28 | ||
| Price, 1D Change | - | |
| $558K | ||
| - | ||
| 0.01 | ||
| - | ||
| $2M | ||
| Revenue, 1Y Change | +100.00% | |
| -$989.53 | ||
| EPS, 1Y Change | +62.73% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:16 | |
| Next Split | N/A | N/A |
| Last Ticker Change | APRI | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$989.53 | ||
| EPS Estimate | N/A | -$4.09 |
| EPS Est. Change | N/A | +99.59% |
| $2.20M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.28 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.41 | -$989.53 | -241,247.76% | |
| -$4.09 | N/A | +99.59% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.20M | $2.20M | 0.00% | |
| - | N/A | - | |
| $28.40M | N/A | +1,189.15% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +100.00% | ||
| +100.00% | ||
| +62.73% | ||
| +39.61% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.28 | ||
| $1.28 | ||
| SMA 200 vs Price | 0.00% | |
| $1.28 | ||
| SMA 50 vs Price | 0.00% | |
| - | ||
| $0.00 | ||
| 0.00 | ||
| - | ||
| - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $2.20M | ||
| -$989.53 | ||
| $2.15M | ||
| 97.41% | ||
| -$40.50M | ||
| -1,838.36% | ||
| -$37.88M | ||
| -1,719.56% | ||
| -$37.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.42 | ||
| 0.14 | ||
| 0.14 | ||
| - | ||
| 5 | ||
| -95.32 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 0.28 | ||
| -0.02 | ||
| -0.35 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$33.51M | ||
| $3.00M | ||
| $5.42M | ||
| $5.40M | ||
| $38.93M | ||
| $38.93M | ||
| $14.23M | ||
| $14.23M | ||
| $16.40M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $40.50M | ||
| $40.50M | ||
| $57.00K | ||
| $12.59M | ||
| $57.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$23.91M | ||
| $0.00 | ||
| $11.38M | ||
| $0.00 | ||
| -$23.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Guggenheim | → | |
| Cantor Fitzgerald | → | |
| Benchmark | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Benchmark | → | |
| BTIG | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with SEEL
FAQ
What is the ticker symbol for Seelos Therapeutics, Inc.?
The ticker symbol for Seelos Therapeutics, Inc. is NASDAQ:SEEL
Does Seelos Therapeutics, Inc. pay dividends?
No, Seelos Therapeutics, Inc. does not pay dividends
What sector is Seelos Therapeutics, Inc. in?
Seelos Therapeutics, Inc. is in the Healthcare sector
What industry is Seelos Therapeutics, Inc. in?
Seelos Therapeutics, Inc. is in the Biotechnology industry
What country is Seelos Therapeutics, Inc. based in?
Seelos Therapeutics, Inc. is headquartered in United States
When did Seelos Therapeutics, Inc. go public?
Seelos Therapeutics, Inc. initial public offering (IPO) was on April 19, 1999
Is Seelos Therapeutics, Inc. in the S&P 500?
No, Seelos Therapeutics, Inc. is not included in the S&P 500 index
Is Seelos Therapeutics, Inc. in the NASDAQ 100?
No, Seelos Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Seelos Therapeutics, Inc. in the Dow Jones?
No, Seelos Therapeutics, Inc. is not included in the Dow Jones index
When was Seelos Therapeutics, Inc. last earnings report?
Seelos Therapeutics, Inc.'s most recent earnings report was on November 21, 2024
When does Seelos Therapeutics, Inc. report earnings?
The date for Seelos Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- SEEL Official Website seelostherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1017491/000141057824001435/0001410578-24-001435-index.htm
- SEEL Profile on Yahoo Finance finance.yahoo.com/quote/SEEL
- SEEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/seel